Such a penny stock of China SXT Pharmaceuticals is climbing now on huge volume by 95%. It started surging in premarket without any news. Since March 2019 the stock has been only declining by facing no significant bumps. There was no announcement of the share repurchase program. Perhaps, someone is investing to make one day rebounding for the SXTC shares with intention of holding them in long term.
China SXT manufactures traditional Chinese drugs that are widely used by households in China while local retailers can even make the drugs themselves. The company isn’t a monopolist in the gigantic market but could improve its branding by offering diversified products. Soon it will do that because it is the only way to gain different market shares.